Azenta, Inc.

This Current Report on Form 8-K and the press release furnished as Exhibit 99.1 contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements concerning anticipated capital deployment and equipment purchases; potential exercise of the perpetual-license option; regional production deployments; integration of SynPlexity’s technology; potential contingent payments; and expected benefits of the transactions, including improvements in synthesis speed, scalability, construct complexity, manufacturing efficiency and the expansion of the Company’s offerings and markets. Forward-looking statements are based on management’s current expectations and assumptions and are not guarantees of future performance.

Actual results could differ materially as a result of risks and uncertainties, including the Company’s ability to complete technology transfer, validate and scale the licensed platform, and integrate the acquired technology and personnel; dependence on Elegen for technology, consumables, equipment, software and support and Elegen’s ability to perform its obligations; maintenance of license exclusivity and continuity of supply; intellectual property rights, contractual restrictions and changes in control of Elegen; the pace of technological change and competitive developments; customer adoption and demand; the timing and cost of deployment; and the Company’s ability to realize the anticipated benefits. These risks are in addition to those described in the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made. Except as required by law, the Company undertakes no obligation to update them.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits